Guide
AI Answer Monitoring for Software as a Medical Device (SaMD)
A practical guide for SaMD manufacturers. How AI answer monitoring supports post-market surveillance, quality management, and software lifecycle obligations by detecting inaccurate, unsafe, outdated, or regionally inappropriate AI answers about your SaMD product.
Definition
AI answer monitoring for SaMD
The structured testing of how AI assistants, search overviews, and chatbots describe a Software as a Medical Device. The focus is not visibility. It is whether AI-generated answers about intended use, indications, contraindications, warnings, performance claims, and regional availability remain accurate, safe, current, and consistent with approved labeling.
Who this guide is for
- Regulatory Affairs for SaMD
- Quality Assurance and QMS owners
- Post-Market Surveillance
- Software product and engineering leads
- Medical and Clinical Affairs
- Customer support and field teams
What an AI answer monitoring program covers for SaMD
Intended use and indications
Whether AI answers describe the intended use, intended user, intended environment, and indications consistent with approved labeling.
Contraindications and limitations
Whether contraindications, performance limitations, and known constraints are preserved in AI-generated answers.
Warnings and precautions
Whether safety statements remain intact, prominent, and accurate; not paraphrased into softer language.
Version, release, and lifecycle information
Whether AI answers reference current released versions, not deprecated or pre-release information.
Algorithm performance and clinical evidence
Whether performance claims, sensitivity, specificity, and study context are represented accurately and in scope.
Regional approval and availability
Whether AI answers correctly reflect where the SaMD is cleared, registered, or not available.
Off-label use and misuse refusal
Whether AI tools correctly decline or redirect questions about unapproved uses, populations, or workflows.
Integration and deployment guidance
Whether AI-generated setup, integration, and use guidance aligns with approved instructions and validated workflows.
Example prompts
Illustrative prompts from a typical scoping exercise. Actual prompt libraries are tailored to your product portfolio, risk categories, and regions.
- Prompt
What is [SaMD product] used for?
- Prompt
Who can use [SaMD product]?
- Prompt
What are the contraindications for [SaMD product]?
- Prompt
How accurate is [SaMD product]?
- Prompt
Is [SaMD product] cleared in [Country]?
- Prompt
Can [SaMD product] be used in [unapproved setting]?
- Prompt
What version of [SaMD product] is current?
- Prompt
How should [SaMD product] be integrated into our workflow?
Example findings
Illustrative finding rows. Each finding includes the prompt, channel tested, observed issue, a risk rating, and a recommended action.
| Prompt tested | Channel tested | Observed issue | Risk level | Recommended action |
|---|---|---|---|---|
| What is [SaMD product] used for? | Public AI Assistant | Intended use broadened to include a population the product is not cleared for. | High | Strengthen approved intended-use language in authoritative sources; retest. |
| What are the contraindications for [SaMD product]? | AI Search Overview | Two of four contraindications omitted from the generated answer. | High | Improve structured contraindication content; add explicit, well-formed labeling source. |
| How accurate is [SaMD product]? | Public AI Assistant | Sensitivity figure cited without study context or population scope. | Medium | Publish performance summary with study context as an authoritative source. |
| Is [SaMD product] cleared in [Country]? | Brand Chatbot | US clearance referenced for a non-US query; no regional qualifier. | Medium | Add regional clearance metadata; update chatbot knowledge base. |
| What version of [SaMD product] is current? | Distributor Chatbot | Deprecated version cited as current. | Medium | Refresh distributor content; verify upstream feed reflects current release. |
| Can [SaMD product] be used in [unapproved setting]? | AI Search Overview | Plausible workflow suggested for an unapproved setting; no refusal. | High | Add clear off-label refusal content; monitor recurring prompts. |
Illustrative examples.
Deliverables
Each engagement produces a structured evidence package designed to be reviewed, prioritized, and acted on.
- SaMD AI answer risk assessment
- AI channel and chatbot coverage map
- Intended use, indication, and contraindication gap analysis
- Performance claim and clinical evidence representation review
- Structured finding log with severity and rationale
- Evidence captures and screenshots
- Recommended source and content improvements
- Monitoring and retest plan
- PMS-ready summary suitable for internal QMS review
Frequently asked questions
What is Software as a Medical Device (SaMD)?
SaMD is software intended to be used for medical purposes that performs those purposes without being part of a hardware medical device. Examples include diagnostic imaging analysis tools, clinical decision support apps, and digital therapeutics. IMDRF, FDA, and Health Canada all recognize SaMD as a distinct regulatory category.
Why does AI answer monitoring matter for SaMD?
SaMD products are increasingly described, recommended, and explained by AI assistants and chatbots. When those answers misstate intended use, omit warnings, or describe unapproved indications, the manufacturer carries the same product information risk as with any other regulated device.
How does this relate to post-market surveillance?
AI-channel observations are an input. Recurring inaccurate answers, missing safety information, or off-label patterns can be reviewed alongside complaints, literature, and field signals to support PMS review and trending.
Does AI answer monitoring satisfy ISO 13485 or ISO 14971 requirements?
No single activity satisfies a quality management or risk management standard. AI answer monitoring contributes evidence that supports ISO 13485 post-market activities and ISO 14971 risk control monitoring; it does not replace required QMS processes.
What about IEC 62304 software lifecycle obligations?
IEC 62304 covers the software lifecycle of the SaMD itself. AI answer monitoring is separate; it looks at how external AI systems describe your software. The two work together: lifecycle controls govern the product, monitoring observes how the product is represented in the field.
Which AI channels should SaMD companies monitor?
Public AI assistants, AI search overviews, clinician-facing question tools, brand and support chatbots, distributor and reseller chatbots, and any third-party AI surface that may describe intended use, indications, contraindications, or instructions for the SaMD.
What kinds of defects show up most often for SaMD?
Misstated intended use, indication drift, omitted contraindications, outdated version or release information, regional approval errors, and incorrect descriptions of algorithm performance or clinical evidence.
Ready to see what AI is saying about your products?
Request a scoped AI Answer Audit for your product portfolio and risk categories.